OTCMKTS:CVSI

CV Sciences (CVSI) Stock Forecast, Price & News

$0.05

0.00 (-5.00%)

(As of 06/2/2023 08:49 PM ET)

Compare

Today's Range: $0.04
▼
$0.05
50-Day Range: $0.04
▼
$0.05
52-Week Range: $0.03
▼
$0.07

Volume: 75,900 shs
Average Volume: 227,864 shs
Market Capitalization: $6.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Earnings Financials Insider Trades Headlines SEC Filings Short Interest

About CV Sciences (OTCMKTS:CVSI) Stock

CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the following segments: Consumer Products and Specialty Pharmaceutical. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.

Receive CVSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter.

CVSI Stock News Headlines

June 1, 2023 | finance.yahoo.com

CV Sciences to Participate in LD Micro Invitational Conference

May 15, 2023 | msn.com

CV Sciences Inc Q1 Revenue Stagnates YoY, Here Is What You Need To Know

June 5, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

May 15, 2023 | finance.yahoo.com

CV Sciences, Inc. Reports First Quarter 2023 Financial Results

May 14, 2023 | markets.businessinsider.com

CV Sciences earnings: here's what Wall Street expects

May 9, 2023 | finance.yahoo.com

CV SCIENCES, INC. TO ANNOUNCE FIRST QUARTER 2023 RESULTS ON MAY 15, 2023

April 9, 2023 | finance.yahoo.com

CV Sciences, Inc. (PNK:CVSI) Q4 2022 Earnings Call Transcript

April 3, 2023 | finance.yahoo.com

CV Sciences, Inc. Introduces New THC Offering

June 5, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

March 29, 2023 | msn.com

CV Sciences FY22 Revenue Declines 19% To $16.2M

March 29, 2023 | finance.yahoo.com

CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results

March 28, 2023 | markets.businessinsider.com

CV Sciences is about to announce its earnings — here's what to expect

March 25, 2023 | finance.yahoo.com

CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023

March 23, 2023 | finance.yahoo.com

CV Sciences Receives Formal Notice of Patent Issuance from Japan Patent Office for Formulations Containing Cannabidiol (CBD) and Nicotine for Treating Smokeless Tobacco Addiction

March 21, 2023 | finance.yahoo.com

CV Sciences, Inc. Launches New Line of THC-Free Gummies and Softgels

March 4, 2023 | benzinga.com

CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

January 18, 2023 | finance.yahoo.com

CV Sciences, Inc. Launches 30-Count of Popular +PlusCBD™ Reserve Collection Softgels

January 14, 2023 | benzinga.com

CV Sciences Stock (OTC:CVSI), Quotes and News Summary

December 20, 2022 | proactiveinvestors.com

CV Sciences seeing strong consumer response to Reserve Collection and Wellness Line of products

November 14, 2022 | msn.com

Why Is CV Sciences Stock Up Today?

November 14, 2022 | seekingalpha.com

CV Sciences, Inc. (CVSI) Q3 2022 Earnings Call Transcript

November 14, 2022 | finance.yahoo.com

CV Sciences, Inc. Reports Third Quarter 2022 Financial Results

November 8, 2022 | finance.yahoo.com

CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

October 1, 2022 | seekingalpha.com

CVSI CV Sciences, Inc.

August 25, 2022 | finance.yahoo.com

CV Sciences, Inc. Extinguishes Convertible Debt

August 17, 2022 | stockhouse.com

CV Sciences, Inc. Announces Launch of PlusCBD(TM) Reserve Collection Softgels

August 15, 2022 | seekingalpha.com

CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2022 Results - Earnings Call Transcript

See More Headlines

CVSI Price History

30 days | 90 days | 365 days | Advanced Chart

CVSI Company Calendar

Last Earnings: 3/29/2023
Today: 6/04/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:CVSI
Previous Symbol: NASDAQ:CVSI
CUSIP: N/A
CIK: 1510964
Web: www.cvsciences.com
Phone: (866) 290-2157
Fax: 619-876-4321
Employees: 91
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,210,000.00
Net Margins: -1.83%
Pretax Margin: -2.13%
Return on Equity: -15.47%
Return on Assets: -2.11%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.60
Quick Ratio: 0.56

Sales & Book Value

Annual Sales: $16.20 million
Price / Sales: 0.43
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.03 per share
Price / Book: 1.52

Miscellaneous

Outstanding Shares: 152,100,000
Free Float: 151,922,000
Market Cap: $6.94 million
Optionable: Not Optionable
Beta: 0.96

Key Executives

Joseph D. Dowling
Chief Executive Officer, Secretary & Director

Joerg Grasser
Chief Financial Officer

Stuart Tomc
Vice President-Human Nutrition

Key Competitors

View All Competitors

CVSI Stock - Frequently Asked Questions

How have CVSI shares performed in 2023?: CV Sciences' stock was trading at $0.0324 on January 1st, 2023. Since then, CVSI stock has increased by 40.7% and is now trading at $0.0456.
View the best growth stocks for 2023 here.
Are investors shorting CV Sciences?: CV Sciences saw a increase in short interest in May. As of May 15th, there was short interest totaling 43,400 shares, an increase of 20.2% from the April 30th total of 36,100 shares. Based on an average daily trading volume, of 315,500 shares, the short-interest ratio is presently 0.1 days.
View CV Sciences' Short Interest.
How were CV Sciences' earnings last quarter?: CV Sciences, Inc. (OTCMKTS:CVSI) announced its quarterly earnings results on Wednesday, March, 29th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm earned $3.87 million during the quarter. CV Sciences had a negative trailing twelve-month return on equity of 15.47% and a negative net margin of 1.83%.
What other stocks do shareholders of CV Sciences own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CV Sciences investors own include Aurora Cannabis (ACB), Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), Organigram (OGI), GW Pharmaceuticals (GWPH), Tilray (TLRY) and Medical Marijuana (MJNA).

What is CV Sciences' stock symbol?: CV Sciences trades on the OTCMKTS under the ticker symbol "CVSI."
How do I buy shares of CV Sciences?: Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is CV Sciences' stock price today?: One share of CVSI stock can currently be purchased for approximately $0.05.
How much money does CV Sciences make?: CV Sciences (OTCMKTS:CVSI) has a market capitalization of $6.94 million and generates $16.20 million in revenue each year. The company earns $-8,210,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis.
How can I contact CV Sciences?: CV Sciences' mailing address is 10070 BARNES CANYON ROAD, SAN DIEGO CA, 92121. The official website for the company is www.cvsciences.com. The company can be reached via phone at (866) 290-2157, via email at ir@cvsciences.com, or via fax at 619-876-4321.

This page (OTCMKTS:CVSI) was last updated on 6/5/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial